Globus Medical Balance Sheet Health

Financial Health criteria checks 5/6

Globus Medical has a total shareholder equity of $4.0B and total debt of $417.4M, which brings its debt-to-equity ratio to 10.4%. Its total assets and total liabilities are $5.1B and $1.1B respectively. Globus Medical's EBIT is $273.5M making its interest coverage ratio -13.6. It has cash and short-term investments of $517.8M.

Key information

10.4%

Debt to equity ratio

US$417.40m

Debt

Interest coverage ratio-13.6x
CashUS$517.79m
EquityUS$4.00b
Total liabilitiesUS$1.09b
Total assetsUS$5.09b

Recent financial health updates

Recent updates

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Apr 08
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Mar 20
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Feb 09
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Jan 17
Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Globus Medical: Merger Overhang Lingering

Nov 27

Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Nov 14
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Oct 27
Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jul 11
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Jun 18
Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Apr 09
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Mar 22
What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Feb 24
Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Globus Medical Q4 2022 Earnings Preview

Feb 20

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line

Nov 08

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact

Sep 02

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective

Jun 05

Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

May 24
Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

May 06
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Mar 14
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Globus Medical Continues To Flex Its Innovation Muscles To Drive Share Growth

Mar 01

Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Feb 24
Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Feb 08
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jan 21
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?

Nov 28
Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Nov 10
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?

Oct 19
At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?

Financial Position Analysis

Short Term Liabilities: GMED's short term assets ($1.9B) exceed its short term liabilities ($392.3M).

Long Term Liabilities: GMED's short term assets ($1.9B) exceed its long term liabilities ($695.8M).


Debt to Equity History and Analysis

Debt Level: GMED has more cash than its total debt.

Reducing Debt: GMED's debt to equity ratio has increased from 0% to 10.4% over the past 5 years.

Debt Coverage: GMED's debt is well covered by operating cash flow (58.3%).

Interest Coverage: GMED earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.